Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Pharmacogenomic study—A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention

    To investigate factors affecting the efficacy and tolerability of verapamil for migraine prevention using individual pharmacogenomic phenotypes.

    Yi-Chieh Chen, Han Wang, Jayawant N. Mandrekar in The Pharmacogenomics Journal (2024)

  2. Article

    Open Access

    Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)

    The objective of this study was to discover clinical and pharmacogenetic factors associated with bevacizumab-related gastrointestinal hemorrhage in Cancer and Leukemia Group B (Alliance) 90401. Patients with m...

    Jai N. Patel, Chen Jiang, Kouros Owzar, Daniel L. Hertz in The Pharmacogenomics Journal (2024)

  3. No Access

    Article

    Knowledge and attitudes of medical and pharmacy students about pharmacogenomics: a systematic review and meta-analysis

    Pharmacogenomics (PGx) is rapidly growing branch of molecular genetics with high potentials to influence therapeutics. This review evaluates knowledge and attitudes of medical and pharmacy students about PGx. ...

    Chen Li, **aona Su, Qidi Sun, Yi Huang in The Pharmacogenomics Journal (2023)

  4. No Access

    Article

    Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population

    Major depressive disorder (MDD) is associated with high heterogeneity in clinical presentation. In addition, response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably among...

    Shiau-Shian Huang, Yi-Ting Chen, Mei-Hsin Su, Shih-Jen Tsai in The Pharmacogenomics Journal (2023)

  5. Article

    Open Access

    Publisher Correction: Cyrius: accurate CYP2D6 genoty** using whole-genome sequencing data

    **ao Chen, Fei Shen, Nina Gonzaludo, Alka Malhotra in The Pharmacogenomics Journal (2022)

  6. No Access

    Article

    Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial

    Polymorphisms in genes associated with opioid signaling and dopamine reuptake and inactivation may moderate naltrexone efficacy in Alcohol Use Disorder (AUD), but the effects of epigenetic modification of thes...

    Joseph P. Schacht, Michaela Hoffman, Brian H. Chen in The Pharmacogenomics Journal (2022)

  7. Article

    Open Access

    New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin

    Although a few studies have reported the effects of several polymorphisms on major adverse cardiovascular events (MACE) in patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronar...

    **aomin Liu, Hanshi Xu, Huaiqian Xu, Qingshan Geng in The Pharmacogenomics Journal (2021)

  8. No Access

    Article

    The variants at FLNA and FLNB contribute to the susceptibility of hypertension and stroke with differentially expressed mRNA

    Filamin A and filamin B were involved in vascular development and remodeling. Herein, it is important to explore the associations of FLNA and FLNB variants with hypertension and stroke.

    Chunlan Liu, Wuzhuang Tang, Hailong Zhao, Song Yang in The Pharmacogenomics Journal (2021)

  9. No Access

    Article

    Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients

    The aim of this study was to identify novel genetic variants affecting tacrolimus trough blood concentrations. We analyzed the association between 58 single nucleotide polymorphisms (SNPs) across the CYP3A gene c...

    Dina Chen, Huijie Lu, Weiguo Sui, Liqing Li, Jian Xu in The Pharmacogenomics Journal (2021)

  10. Article

    Open Access

    Cyrius: accurate CYP2D6 genoty** using whole-genome sequencing data

    Responsible for the metabolism of ~21% of clinically used drugs, CYP2D6 is a critical component of personalized medicine initiatives. Genoty** CYP2D6 is challenging due to sequence similarity with its pseudogen...

    **ao Chen, Fei Shen, Nina Gonzaludo, Alka Malhotra in The Pharmacogenomics Journal (2021)

  11. No Access

    Article

    Predictive value of genetic variants XRCC1 rs1799782, APEX1 rs1760944, and MUTYH rs3219489 for adjuvant concurrent chemoradiotherapy outcomes in oral squamous cell carcinoma patients

    Genetic variations in DNA base excision repair (BER) genes may affect tumor sensitivity to chemotherapy and radiotherapy. Thus, we investigated the effects of single-nucleotide polymorphisms (SNPs) in key BER ...

    Thomas Senghore, Huei-Tzu Chien, Wen-Chang Wang in The Pharmacogenomics Journal (2020)

  12. No Access

    Article

    A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan Biobank

    An imputation algorithm for human leukocyte antigen (HLA) is helpful for exploring novel disease associations. However, population-specific HLA imputation references are essential for achieving high imputation ac...

    Yu-Han Huang, Seik-Soon Khor, **uwen Zheng, Hsuan-Yu Chen in The Pharmacogenomics Journal (2020)

  13. No Access

    Article

    A methylation functional detection hepatic cell system validates correlation between DNA methylation and drug-induced liver injury

    Drug-induced liver injury (DILI) is a life-threatening, adverse reaction to certain drugs. The onset and extent of DILI can vary drastically in different patients using identical drugs. Association studies sug...

    Yuqi Wei, Cong Huai, Chenxi Zhou, Yaqi Gao, Luan Chen in The Pharmacogenomics Journal (2020)

  14. Article

    Open Access

    Identification of gene modules associated with survival of diffuse large B-cell lymphoma treated with CHOP-based chemotherapy

    Diffuse Large B-cell Lymphoma (DLBCL), a heterogeneous disease, is influenced by complex network of gene interactions. Most previous studies focused on individual genes, but ignored the importance of intergeni...

    YongChao Gao, Bao Sun, **gLei Hu, Huan Ren, HongHao Zhou in The Pharmacogenomics Journal (2020)

  15. No Access

    Article

    High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma

    The prognosis role of CCT3 in MM and the possible pathways it involved were studied in our research. By analyzing ten independent datasets (including 48 healthy donors, 2220 MM, 73 MGUS, and 6 PCL), CCT3 was foun...

    Tingting Qian, Longzhen Cui, Yan Liu, Zhiheng Cheng in The Pharmacogenomics Journal (2020)

  16. No Access

    Article

    Prognostic role of SCAMP family in acute myeloid leukemia

    Acute myeloid leukemia (AML) is a malignant disease of myeloid hematopoietic stem or progenitor cells characterized by abnormal proliferation of primary and immature myeloid cells in bone marrow and peripheral...

    Tingting Qian, Zhiheng Cheng, Liang Quan, Tiansheng Zeng in The Pharmacogenomics Journal (2020)

  17. Article

    Open Access

    Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers

    Nicotine is the major pharmacologically active substance in tobacco. Several studies have examined genotypes related to nicotine metabolism, but few studies have been performed in the Mexican population. The o...

    Gissela Borrego-Soto, Yadira X. Perez-Paramo, Gang Chen in The Pharmacogenomics Journal (2020)

  18. No Access

    Article

    Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome

    Few studies have investigated the correlation between pharmacogenomics and tacrolimus pharmacokinetics in patients with nephrotic syndrome (NS). This study evaluated the influences of genetic polymorphisms of ...

    **aolan Mo, Jiali Li, Yunfeng Liu, **n Liao, Mei Tan in The Pharmacogenomics Journal (2020)

  19. No Access

    Article

    HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population

    Tanshinone, a widely used Chinese patent medicine, has been confirmed to have various kinds of pharmacological effects although frequently causing cutaneous adverse drug reactions (cADRs). We aim to identify w...

    Qinyuan Zhu, Yanzhou Zhang, Jiekun Xuan, Fan** Yang in The Pharmacogenomics Journal (2020)

  20. No Access

    Article

    An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients

    Thiopurines are used in the treatment of inflammatory bowel disease (IBD) but remain clinically challenging to manage due to wide interpatient variability in clinical outcomes and adverse events. Apart from ge...

    Sylvia Chen, Wei Zhi Tan, Natalia Sutiman, Cindy Lim in The Pharmacogenomics Journal (2020)

previous disabled Page of 4